Stage Alpha
Cancer develops in steps, starting before cancer forms. The earlier it’s found, the more options there are.
Redefining the starting line
Cancer doesn’t appear all at once. It develops in steps, and the earliest steps happen before a scan or biopsy can find anything. We act as early on that path as we can: before cancer forms, while changes are still precancerous, or while cancer is small and contained.
Standard cancer staging starts at Stage 0, when changed cells are already there and can be seen. But that isn’t where the process starts. Your genes, your family history, and small shifts in your blood work can point to higher risk well before that.
Stage Alpha is the name for that earlier window. It’s the point where prevention, closer monitoring, and a plan built around you can make the biggest difference.
The Stage Alpha framework
Standard care asks what stage a cancer has reached. We ask a different question: based on your biology, what’s the earliest point we can act with confidence?
To answer it, we look at four kinds of signals together. On its own, one small change may mean little. Tracked against your own baseline over time, and alongside other signals, it can show something worth a closer look.
Genomic signals
Your DNA, read once and re-read as science advances. It finds inherited changes that raise your cancer risk before any symptoms appear.
Clinical signals Monitored
Circulating biomarkers
Tiny pieces of material that cancer cells can shed into your blood, sometimes before a tumor can be seen. These include DNA, proteins, and metabolic signals.
Clinical signals Monitored
Imaging signals
Advanced imaging, analyzed with AI, that can spot small tissue changes a standard read may miss, before a tumor is visible.
Clinical signals Monitored
Radiomic anomaly scores
AI-detected tissue changesWhole-body MRIPre-mass formation findings
Biochemical signals
Blood markers followed over time. A steady shift, especially alongside other signals, can point to something worth checking.
Clinical signals Monitored
Tumor-associated biomarkers
Inflammation and immune markersMetabolic and hormone-related markers
Organ function and tissue-stress markers
Persistent abnormal patterns
Turning the science into a plan for you
Until now, no clinical program has been built for this early window. The Virtual Prevention & Early Detection Clinic changes that. We estimate your risk, build a test plan around it, and follow your results over time, updating the plan as the science improves. A board-certified medical oncologist reviews every plan, and your primary care doctor stays informed.